Phase 1/2 Clinical Trial Evaluating 4d-310 In Adults With Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 21-42 Months of Follow Up
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:55:202025-02-06 11:16:34Phase 1/2 Clinical Trial Evaluating 4d-310 In Adults With Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 21-42 Months of Follow Up